American pharmaceutical company. Its products range from covid-19 vaccines to Viagra. In 2025 Pfizer reported declining sales and earnings, and won a bidding war with Novo Nordisk over Metsera, a developer of anti-obesity drugs, raising its offer from $7bn to $10bn. The same year Pfizer agreed to pay $1.25bn in fees to 3SBio, a Chinese biotech firm, for the rights to manufacture and sell an experimental cancer drug outside China, if approved.
The more we disagree, the more chance there is that at least one of us is right.